Cargando…
Plasma amyloid and tau as dementia biomarkers in Down syndrome: Systematic review and meta‐analyses
Individuals with Down syndrome (DS) are at high risk of developing Alzheimer's disease (AD). Discovering reliable biomarkers which could facilitate early AD diagnosis and be used to predict/monitor disease course would be extremely valuable. To examine if analytes in blood related to amyloid pl...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790908/ https://www.ncbi.nlm.nih.gov/pubmed/31389176 http://dx.doi.org/10.1002/dneu.22715 |